EFfect of C.Palmitole(Palmtoylethanolamide,Genistein,Diadzein) in treating Nerves affected by Diabetes
Phase 4
- Conditions
- Health Condition 1: E114- Type 2 diabetes mellitus with neurological complications
- Registration Number
- CTRI/2024/02/063245
- Lead Sponsor
- Government Kilpauk Medical College
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Open to Recruitment
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
Clinically diagnosed with neuropathy using diagnostic tests (Tip-Therm test, Monofilament test, Biothesiometry) at the Diabetology Clinic in our hospital
Participants exhibiting neuropathic pain scoring more than 4 on Neuropathic Pain Diagnostic Questionnaire(DN4) and scoring more than 12 on S-LANSS (Self reported Leeds Assessment of Neuropathic Symptoms and Signs(S-LANSS)
Exclusion Criteria
Participants with Type1 diabetes mellitus, not willing to participant,pregnant and lactating mothers, history of hypersensitivity,those who are on longterm steroid, those wtih documented history of other neuropathies
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Diabetic Neuropathy pain score assesed using BPI-DPN Pain scale with FBS,PPBSTimepoint: at Baseline,4,8,12 weeks
- Secondary Outcome Measures
Name Time Method Participants will be assessed clinically by Tip-Therm test, Monofilament test, Biothesiometr,CBC, RFT, LFT, Lipid profileTimepoint: At baseline and at 12 weeks